Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens

Junji Ichikawa, Toshihide Kuroki, Herbert Y. Meltzer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The effect of chronic treatment with the tricyclic antidepressant drug, imipramine (10 mg/kg per day), the selective serotonin (5-HT) reuptake inhibitor, fluoxetine hydrochloride (10 mg/kg per day), and vehicle, in drinking water for 24-28 days followed by 3-5 days withdrawal, on extracellular dopamine levels was studied in rat nucleus accumbens by in vivo microdialysis. Basal extracellular dopamine levels in the nucleus accumbens were increased after chronic imipramine (12.7 ± 1.5 fmol/20 μl per 30 min, P = 0.019), and moderately decreased after chronic fluoxetine (6.5 ± 0.6, P = 0.047), as compared to the vehicle controls (9.1 ± 0.7), determined by one-way analysis of variance (ANOVA). Repeated measure ANOVA indicated that the D-amphetamine sulfate (0.5 mg/kg, s.c.)-induced increase in extracellular dopamine levels in the nucleus accumbens was potentiated after chronic imipramine (P = 0.002), but unchanged after chronic fluoxetine (P = 0.83). The difference in the effect of amphetamine could be influenced by the significant differences in basal levels. However, these results were also confirmed by analysis of the net area under the curve (net-AUC) for a 180- min period (six samples): for chronic imipramine (337 ± 45 fmol/180 min, P = 0.005) and chronic fluoxetine (249 ± 38, P = 0.57), as compared to the vehicle controls (178 ± 29), determined by one-way ANOVA. We suggest that the effect of treatment with these agents on mesolimbic dopamine is unlikely to be involved in their shared antidepressant action, but may be relevant to other aspects of the therapeutic profile of these two drugs, e.g. the switch into mania which is more common after treatment with imipramine than fluoxetine and exacerbation of positive symptoms in patients with schizophrenia or schizoaffective disorder.

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalEuropean Journal of Pharmacology
Volume350
Issue number2-3
DOIs
Publication statusPublished - Jun 5 1998
Externally publishedYes

Fingerprint

Imipramine
Fluoxetine
Nucleus Accumbens
Amphetamine
Dopamine
Analysis of Variance
Serotonin
Tricyclic Antidepressive Agents
Microdialysis
Bipolar Disorder
Drinking Water
Psychotic Disorders
Antidepressive Agents
Area Under Curve
Schizophrenia
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens. / Ichikawa, Junji; Kuroki, Toshihide; Meltzer, Herbert Y.

In: European Journal of Pharmacology, Vol. 350, No. 2-3, 05.06.1998, p. 159-164.

Research output: Contribution to journalArticle

@article{136d34bd1cae44daae9c574f06c57e6d,
title = "Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens",
abstract = "The effect of chronic treatment with the tricyclic antidepressant drug, imipramine (10 mg/kg per day), the selective serotonin (5-HT) reuptake inhibitor, fluoxetine hydrochloride (10 mg/kg per day), and vehicle, in drinking water for 24-28 days followed by 3-5 days withdrawal, on extracellular dopamine levels was studied in rat nucleus accumbens by in vivo microdialysis. Basal extracellular dopamine levels in the nucleus accumbens were increased after chronic imipramine (12.7 ± 1.5 fmol/20 μl per 30 min, P = 0.019), and moderately decreased after chronic fluoxetine (6.5 ± 0.6, P = 0.047), as compared to the vehicle controls (9.1 ± 0.7), determined by one-way analysis of variance (ANOVA). Repeated measure ANOVA indicated that the D-amphetamine sulfate (0.5 mg/kg, s.c.)-induced increase in extracellular dopamine levels in the nucleus accumbens was potentiated after chronic imipramine (P = 0.002), but unchanged after chronic fluoxetine (P = 0.83). The difference in the effect of amphetamine could be influenced by the significant differences in basal levels. However, these results were also confirmed by analysis of the net area under the curve (net-AUC) for a 180- min period (six samples): for chronic imipramine (337 ± 45 fmol/180 min, P = 0.005) and chronic fluoxetine (249 ± 38, P = 0.57), as compared to the vehicle controls (178 ± 29), determined by one-way ANOVA. We suggest that the effect of treatment with these agents on mesolimbic dopamine is unlikely to be involved in their shared antidepressant action, but may be relevant to other aspects of the therapeutic profile of these two drugs, e.g. the switch into mania which is more common after treatment with imipramine than fluoxetine and exacerbation of positive symptoms in patients with schizophrenia or schizoaffective disorder.",
author = "Junji Ichikawa and Toshihide Kuroki and Meltzer, {Herbert Y.}",
year = "1998",
month = "6",
day = "5",
doi = "10.1016/S0014-2999(98)00247-7",
language = "English",
volume = "350",
pages = "159--164",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens

AU - Ichikawa, Junji

AU - Kuroki, Toshihide

AU - Meltzer, Herbert Y.

PY - 1998/6/5

Y1 - 1998/6/5

N2 - The effect of chronic treatment with the tricyclic antidepressant drug, imipramine (10 mg/kg per day), the selective serotonin (5-HT) reuptake inhibitor, fluoxetine hydrochloride (10 mg/kg per day), and vehicle, in drinking water for 24-28 days followed by 3-5 days withdrawal, on extracellular dopamine levels was studied in rat nucleus accumbens by in vivo microdialysis. Basal extracellular dopamine levels in the nucleus accumbens were increased after chronic imipramine (12.7 ± 1.5 fmol/20 μl per 30 min, P = 0.019), and moderately decreased after chronic fluoxetine (6.5 ± 0.6, P = 0.047), as compared to the vehicle controls (9.1 ± 0.7), determined by one-way analysis of variance (ANOVA). Repeated measure ANOVA indicated that the D-amphetamine sulfate (0.5 mg/kg, s.c.)-induced increase in extracellular dopamine levels in the nucleus accumbens was potentiated after chronic imipramine (P = 0.002), but unchanged after chronic fluoxetine (P = 0.83). The difference in the effect of amphetamine could be influenced by the significant differences in basal levels. However, these results were also confirmed by analysis of the net area under the curve (net-AUC) for a 180- min period (six samples): for chronic imipramine (337 ± 45 fmol/180 min, P = 0.005) and chronic fluoxetine (249 ± 38, P = 0.57), as compared to the vehicle controls (178 ± 29), determined by one-way ANOVA. We suggest that the effect of treatment with these agents on mesolimbic dopamine is unlikely to be involved in their shared antidepressant action, but may be relevant to other aspects of the therapeutic profile of these two drugs, e.g. the switch into mania which is more common after treatment with imipramine than fluoxetine and exacerbation of positive symptoms in patients with schizophrenia or schizoaffective disorder.

AB - The effect of chronic treatment with the tricyclic antidepressant drug, imipramine (10 mg/kg per day), the selective serotonin (5-HT) reuptake inhibitor, fluoxetine hydrochloride (10 mg/kg per day), and vehicle, in drinking water for 24-28 days followed by 3-5 days withdrawal, on extracellular dopamine levels was studied in rat nucleus accumbens by in vivo microdialysis. Basal extracellular dopamine levels in the nucleus accumbens were increased after chronic imipramine (12.7 ± 1.5 fmol/20 μl per 30 min, P = 0.019), and moderately decreased after chronic fluoxetine (6.5 ± 0.6, P = 0.047), as compared to the vehicle controls (9.1 ± 0.7), determined by one-way analysis of variance (ANOVA). Repeated measure ANOVA indicated that the D-amphetamine sulfate (0.5 mg/kg, s.c.)-induced increase in extracellular dopamine levels in the nucleus accumbens was potentiated after chronic imipramine (P = 0.002), but unchanged after chronic fluoxetine (P = 0.83). The difference in the effect of amphetamine could be influenced by the significant differences in basal levels. However, these results were also confirmed by analysis of the net area under the curve (net-AUC) for a 180- min period (six samples): for chronic imipramine (337 ± 45 fmol/180 min, P = 0.005) and chronic fluoxetine (249 ± 38, P = 0.57), as compared to the vehicle controls (178 ± 29), determined by one-way ANOVA. We suggest that the effect of treatment with these agents on mesolimbic dopamine is unlikely to be involved in their shared antidepressant action, but may be relevant to other aspects of the therapeutic profile of these two drugs, e.g. the switch into mania which is more common after treatment with imipramine than fluoxetine and exacerbation of positive symptoms in patients with schizophrenia or schizoaffective disorder.

UR - http://www.scopus.com/inward/record.url?scp=0032486151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032486151&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(98)00247-7

DO - 10.1016/S0014-2999(98)00247-7

M3 - Article

VL - 350

SP - 159

EP - 164

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -